MétaCan
Menu
Back to cohort
Record W4226329947 · doi:10.1016/j.jsxm.2022.01.015

4 The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials

2022· review· en· W4226329947 on OpenAlexaff
Sirpi Nackeeran, Jesse Ory, Daniel Amaro Gonzalez, Taylor P. Kohn, Justin White, Ranjith Ramasamy

Bibliographic record

VenueThe Journal of Sexual Medicine · 2022
Typereview
Languageen
FieldMedicine
TopicHormonal and reproductive studies
Canadian institutionsDalhousie University
Fundersnot available
KeywordsHematocritTestosterone (patch)MedicineRandomized controlled trialPlaceboMeta-analysisIntramuscular injectionInternal medicineUrologyPathology

Abstract

fetched live from OpenAlex

ABSTRACT Introduction Testosterone therapy (TT) is known to be associated with secondary erythrocytosis. Previous studies have shown that method of administration and formulation may result in variances in hematocrit (Hct) increases. Given the increasing demand for TT and newer formulations becoming available, an updated review and meta-analysis of relative increases in hematocrit is warranted. As head-to-head trials are rare, network meta-analysis of the contemporary studies is the only way to compare hematocrit changes by testosterone type, including topical gels and patches, injectables (both short-acting and long-acting) and oral tablets. Objective We aimed to characterize hematocrit changes by testosterone type, including gel, patch, oral testosterone undecanoate (TU), intramuscular (IM) TU, and IM testosterone enanthate/cypionate (TE/C) through a review and meta-analysis of randomized control trials (RCTs) on this topic. Methods We conducted a thorough search of listed publications in Scopus, PubMed, EMBASE, Cochrane CENTRAL, and ClinicalTrials.gov. Twenty-nine placebo-controlled randomized trials (3,393 men) met inclusion criteria for analysis of mean hematocrit change after testosterone therapy. Randomized controlled trial data for the following formulations of testosterone were pooled via network meta-analysis: gel, patch, oral testosterone undecanoate, intramuscular testosterone undecanoate, and intramuscular testosterone enanthate/cypionate. Results All types of testosterone therapies result in statistically significant increases in mean hematocrit when compared with placebo. Meta-analysis revealed all formulations, including gel (3.0%, 95% CI 1.8-4.3%), oral testosterone undecanoate (4.3%, 0.7-8.0%), patch (1.4%, 0.2-2.6%), intramuscular testosterone enanthate/cypionate (4.0%, 2.9-5.1%), and intramuscular testosterone undecanoate (1.6%, 0.3-3.0%) result in statistically significant increases in mean hematocrit when compared with placebo. When comparing all formulations against one another, intramuscular testosterone cypionate/enanthate were associated with a significantly higher increase in mean hematocrit compared to patch, but no differences in hematocrit between other formulations were detected. Conclusions All types of testosterone are associated with increased hematocrit; however, the clinical concern of this increase remains questionable, warranting future studies. This is the first network meta-analysis to quantify mean hematocrit change and compare formulations, given the absence of head-to-head trials. Disclosure No

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.031
metaresearch head score (Gemma)0.074
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (broad)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.984
Threshold uncertainty score0.162

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0310.074
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0160.050
Bibliometrics0.0080.007
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0030.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0060.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.217
GPT teacher head0.429
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Sexual MedicineSame topicHormonal and reproductive studiesFrench-language works237,207